Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR.

Cancer. 2004 Jun 1;100(11):2308-16.

2.

Statins and breast cancer in postmenopausal women without hormone therapy.

Eaton M, Eklof J, Beal JR, Sahmoun AE.

Anticancer Res. 2009 Dec;29(12):5143-8.

3.

Statin use and the risk of breast and prostate cancer.

Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Shapiro S.

Epidemiology. 2002 May;13(3):262-7.

PMID:
11964926
4.

Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.

Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR.

Cancer. 2003 Oct 1;98(7):1504-13.

5.

Statin use and breast cancer: prospective results from the Women's Health Initiative.

Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT; Women's Health Initiative Research Group.

J Natl Cancer Inst. 2006 May 17;98(10):700-7.

6.

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.

Li CI, Weiss NS, Stanford JL, Daling JR.

Cancer. 2000 Jun 1;88(11):2570-7.

PMID:
10861435
7.

Statins and the risk of lung, breast, and colorectal cancer in the elderly.

Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S.

Circulation. 2007 Jan 2;115(1):27-33. Epub 2006 Dec 18.

8.

Hip fracture risk in statin users--a population-based Danish case-control study.

Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sørensen HT, Mosekilde L.

Osteoporos Int. 2004 Jun;15(6):452-8. Epub 2004 Feb 17.

PMID:
15205716
9.

Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.

Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone KE, Marchbanks PA, Simon MS, Ursin G, Weiss LK, Spirtas R.

Contraception. 2004 May;69(5):353-60.

PMID:
15105056
10.

Statin use and risk of breast cancer.

Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM.

Cancer. 2008 Jan 1;112(1):27-33.

11.

Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.

Rejnmark L, Vestergaard P, Mosekilde L.

Calcif Tissue Int. 2006 Jul;79(1):27-36. Epub 2006 Jul 24.

PMID:
16868664
12.

Long-term use of statins and risk of colorectal cancer: a population-based study.

Singh H, Mahmud SM, Turner D, Xue L, Demers AA, Bernstein CN.

Am J Gastroenterol. 2009 Dec;104(12):3015-23. doi: 10.1038/ajg.2009.574. Epub 2009 Oct 6.

PMID:
19809413
13.

Statin use and risk of colorectal cancer.

Coogan PF, Smith J, Rosenberg L.

J Natl Cancer Inst. 2007 Jan 3;99(1):32-40.

14.

Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.

McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1529-37. doi: 10.1158/1055-9965.EPI-13-0414. Epub 2013 Jul 5.

15.

Cigarette smoking and breast cancer.

Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW, Bogdan G, Yuen J.

Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):399-403.

16.

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

Gross CP, Filardo G, Mayne ST, Krumholz HM.

Cancer. 2005 Feb 1;103(3):483-91.

17.

Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.

Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1028-33. doi: 10.1158/1055-9965.EPI-07-0726. Epub 2008 May 7.

18.

Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study.

Ahern TP, Lash TL, Sørensen HT, Pedersen L.

Breast Cancer Res. 2008;10(6):R102. doi: 10.1186/bcr2205. Epub 2008 Dec 3.

19.

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.

20.

Maternal factors and breast cancer risk among young women.

Sanderson M, Williams MA, Daling JR, Holt VL, Malone KE, Self SG, Moore DE.

Paediatr Perinat Epidemiol. 1998 Oct;12(4):397-407.

PMID:
9805713
Items per page

Supplemental Content

Write to the Help Desk